Shell plc (the ‘Company') announces that on 09 December, 2025 it purchased the following number of Shares for cancellation.

Rigetti's weak Q3 and a DARPA Phase B miss weigh on shares, though new contracts and a bold hardware roadmap test investor patience.

Palantir's 151% rally highlights its enterprise AI momentum, rising revenues and robust earnings outlook.

Netflix's $82.7 billion bid for Warner Bros. Discovery is under pressure as Paramount Skydance launches a richer $108.4 billion all-cash offer.

Opendoor Technologies (OPEN) stock has dropped by 24.8% in under a month, from $9.37 on 12th Nov, 2025 to $7.05 currently. What will happen next?

Credo is firing on all cylinders and crushing Wall Street estimates. The company is already profitable, and growth opportunities are expanding. The stock is priced for aggressive expectations but is not overvalued when considering growth potential.

Astera Labs, Inc. (ALAB) Presents at Raymond James TMT & Consumer Conference Transcript

The Goldman Sachs Group, Inc. (GS) Presents at Goldman Sachs 2025 U.S. Financial Services Conference Transcript

Teva holds bullish momentum, trading above key SMAs, as branded drugs and biosimilars drive growth despite generics softness.

CROX's nonstop livestreaming and TikTok dominance spark digital customer gains, helping offset U.S. softness with surging global DTC growth.

San Diego, California--(Newsfile Corp. - December 9, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Perrigo Company plc (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, inclusive (the "Class Period"), have until Friday, January 16, 2026 to seek appointment as lead plaintiff of the Perrigo class action lawsuit. Captioned French v.

IVZ partners with LGT Capital to build a multi-alternative private markets solution, aimed at expanding access for U.S. wealth and retirement investors.

CPB beats EPS estimates even as sales and margins slip, with cost pressures and a planned La Regina stake shaping its 2026 outlook.

San Diego, California--(Newsfile Corp. - December 9, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Stride, Inc. (NYSE: LRN) securities between October 22, 2024 and October 28, 2025, inclusive (the "Class Period"), have until Monday, January 12, 2026 to seek appointment as lead plaintiff of the Stride class action lawsuit. Captioned MacMahon v.

Meta Platforms Inc (NASDAQ:META, XETRA:FB2A, SIX:FB) is developing a new artificial intelligence model, codenamed Avocado, as a potential successor to its Llama series, according to a CNBC report. The model, which is expected to launch in the first quarter of 2026, represents a shift toward a more proprietary approach compared with the open-source Llama family.

Cboe Global Markets, Inc. (CBOE) Presents at Goldman Sachs 2025 U.S. Financial Services Conference Transcript

The Campbell's Company (CPB) Q1 2026 Earnings Call Transcript

Merck holds bullish momentum as pipeline advances and major deals offset vaccine weakness and Keytruda risks.

LOS ANGELES--(BUSINESS WIRE)---- $STOCKS--THE LAW OFFICES OF FRANK R. CRUZ ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS WHO PURCHASED GAUZY Ltd. (“Gauzy” or the “Company”) (NASDAQ: GAUZ) securities between March 11, 2025 and November 13, 2025, inclusive (the “Class Period”). Gauzy investors have until February 6, 2026 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS ON YOUR GAUZY LTD. (GAUZ) INVESTMENTS, CLICK HERE TO SUBMIT A CLAIM TO POTENTIALLY RECOVER YOUR LOSSE.

MONSEY, N.Y., Dec. 09, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed merger of Veeco Instruments, Inc. (Nasdaq: VECO) (“Veeco”) with Axcelis Technologies (“Axcelis”) in an all-stock transaction under which Veeco stockholders will receive 0.3575 shares of Axcelis common stock for each share of Veeco common stock that they own (“Exchange Ratio”).